CHEK1 and cancer: VE‐821 is a ATR inhibitor with potent inhibitory activities on the phosphorylation of H2AX and CHK1 by ATR, and sensitizing effect on cancer cells to radiotherapy and genotoxic chemotherapeutics.66, 231, 377, 378, 379